Publications

Choksi NY, Hussain A, Booth RG. 1996. 2-Phenylaminoadenosine stimulates adenylyl cyclase activity and dopamine biosynthesis through an A2 receptor mediated mechanism. Brain Res 761(1):151–155; doi: 10.1016/s0006-8993(97)00445-9.

Choksi NY, Wyrick SD, Booth RG. Modulation of brain dopamine synthesis in vivo by a putative σ 3 agonist via a G-protein coupled receptor mechanism. Poster presented at Society for Neuroscience Annual Meeting, 1996

Lea IA, Richardson RT, Widgren EE, O’Rand MG. 1996. Cloning and sequencing of cDNAs encoding the human sperm protein, Sp17. Biochim Biophys Acta 1307(3):263–266; doi: 10.1016/0167-4781(96)00077-2.

Covington TR, Clewell HJ III, Gearhart JM, Andersen ME. Developing physiologically-based pharmacokinetic (PB-PK) models for manganese and iron. Poster presented at the Society of Toxicology Annual Meeting, Anaheim, CA, March 1996.

Fraiser LH, Lund LG, Hueske KL, Haws LC. Indirect risk assessment: Case studies of hazardous waste combustors. Society of Toxicology 34th Annual Meeting, Baltimore, MD, March 1995.

Huber KM, Mauk MD, Thompson CM, Kelly PT. 1995. A critical period of protein kinase activity after tetanic stimulation is required for the induction of long-term potentiation. Learn Memor 2:81–100; doi: 10.1101/lm.2.2.81.

Choksi NY, Waller CL, Booth RG. Neurotoxic and neuroprotective effects of polychlorinated biphenyls and adenosine compounds in rat brain. Presented at Society for Neuroscience Annual Meeting, San Diego, CA, November 1995.

Perry CS, Liu XL, Lund LG, Kehrer JP. 1995. Differential toxicities of cyclophosphamide and its glutathione metabolites to A549 cells. Toxicol in Vitro 9(1):21-26; doi: 10.1016/0887-2333(94)00187-Y.

Norton JN, Rylander LA, Richards JL. 1995. In vitro oral mucosa irritation testing with human cell cultures. Toxicol In Vitro 9(1):67–74; 10.1016/0887-2333(94)00189-2.

Prioleau C, Montague DM, Choksi NY, Southerland SB, Lawler CP, Mailman RB. Unusual neurochemical properties of the novel antipsychotic OPC-14597 in rat striatum. Poster presented at Society for Neuroscience Annual Meeting, 1995.

Covington TR, Gearhart JM, Clewell HJ. A physiologically based pharmacokinetic (PBPK) model for 133Xe and 222Rn in the human. Poster presented at the Society of Toxicology Annual Meeting, Baltimore, MD, March 1995.

Haws L. How are we implementing the combustion strategy and indirect risk assessment? Presented at the Texas Natural Resource Conservation Commission Hazardous Waste Seminar, Houston, TX, October 1994.

Gargas M, Norton R, Harris MA, Paustenbach D, Finley B. 1994. Urinary excretion of chromium following ingestion of chromite ore processing residue in humans: Implications for biomonitoring. Risk Anal 14(6):1019-1024; doi: 10.1111/j.1539-6924.1994.tb00071.x.

Haws L. Indirect risk assessment. Presented at the Sixth Annual Texas Environmental Superconference, Austin, TX, August 1994.

Haws LC, Jackson BA, Turnbull D, Dressler WE. 1994. Two approaches for assessing human cancer risk from disperse blue 1. Regul Toxicol Pharmacol. 19(1):80-96; doi: 10.1006/rtph.1994.1007.

Haws L. Overview of TNRCC/EPA concerns, strategies, and schedules concerning indirect risk assessment requirements. Presented at the Workshop on Risk Assessment and Waste Incineration Facilities. Houston, TX, June 28, 1994 and Austin, TX, June 29, 1994.

Haws L. Indirect risk workshop. Panel Discussant. Presented at the RCRA Policy Forum, Washington, DC, January 1994.

Haws L. Keynote Address. Presented at the DRE Environmental Services Workshop on EPA’s New Policy of Hazardous Waste Combustion, Austin, TX, January 1994.

Rish W. 1994. SEC initiatives in environmental disclosure: How can environmental liability be estimated? Ohio Environmental Law Letter 4(6):3–4.

Choksi NY, Hussain A, Owens CE, Myers AM, Harvey RD, Baldessarini RJ, Wyrick SD, Booth RG. Adenosine A2 and PAT- σ3 agonists affect adenylyl cyclase activity and dopamine synthesis. Poster presented at North Carolina Society for Neuroscience Meeting, 1994.